Reena Nakra's most recent trade in Dr. Lal Pathlabs Ltd. was a Disposal of 500 Equity Shares done at an average price of Rs. 3201 . Disclosure was reported to the exchange on Aug. 7, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Reena Nakra in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 07 Aug 2025 | 500 | 8,789 (0.01%) | 0.00% | 3201 | 1,600,500 | 05 Aug 2025 05 Aug 2025 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 22 May 2025 | 300 | 9,589 (0.01%) | 0.00% | 1930.1 | 579,015 | 13 May 2025 13 May 2025 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 22 May 2025 | 300 | 9,289 (0.01%) | 0.00% | 2875 | 862,500 | 21 May 2025 21 May 2025 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 08 May 2025 | 700 | 9,289 (0.01%) | 0.00% | 2810 | 1,967,000 | 06 May 2025 06 May 2025 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 06 May 2025 | 400 | 9,989 (0.01%) | 0.00% | 1930.1 | 772,020 | 02 May 2025 02 May 2025 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 13 Nov 2024 | 300 | 9,589 (0.01%) | 0.00% | 3065 | 919,500 | 12 Nov 2024 12 Nov 2024 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 13 Nov 2024 | 300 | 9,889 (0.01%) | 0.00% | 1930.1 | 579,015 | 07 Nov 2024 07 Nov 2024 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 30 Oct 2024 | 1,450 | 9,589 (0.01%) | 0.00% | 10 | 14,500 | 29 Oct 2024 29 Oct 2024 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 20 Sep 2024 | 1,000 | 8,139 (0.01%) | 0.00% | 3268.0 | 3,267,997 | 19 Sep 2024 19 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 13 Sep 2024 | 1,000 | 9,139 (0.01%) | 0.00% | 3428 | 3,428,000 | 12 Sep 2024 12 Sep 2024 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 14 Jun 2024 | 500 | 10,399 (0.01%) | 0.00% | 2812.4 | 1,406,202 | 06 Jun 2024 13 Jun 2024 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Disposal | 17 May 2024 | 1,000 | 10,889 (0.01%) | 0.00% | 2518.4 | 2,518,374 | 14 May 2024 16 May 2024 |
Insider Trading | Equity Shares | Market Sale |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 16 May 2023 | 1,625 | 11,889 (0.01%) | 0.00% | 10 | 16,250 | 10 May 2023 10 May 2023 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 30 Sep 2021 | 450 | 9,614 (0.01%) | 0.00% | 10 | 4,500 | 28 Sep 2021 28 Sep 2021 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 21 Sep 2021 | 250 | 9,164 (0.01%) | 0.00% | 10 | 2,500 | 20 Sep 2021 20 Sep 2021 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 15 Sep 2021 | 525 | 8,914 (0.01%) | 0.00% | 10 | 5,250 | 13 Sep 2021 13 Sep 2021 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 25 Feb 2021 | 600 | 8,389 (0.01%) | 0.00% | 10 | 6,000 | 23 Feb 2021 23 Feb 2021 |
Insider Trading | Equity Shares | ESOP |
Dr. Lal Pathlabs | Reena Nakra | Designated Person | Acquisition | 07 Jan 2021 | 975 | 7,789 (0.01%) | 0.00% | 10 | 9,750 | 05 Jan 2021 05 Jan 2021 |
Insider Trading | Equity Shares | ESOP |